We reviewed the main findings recent years on the principal molecular actors that are involved in the interactions between MetS and breast cancer biology, including leptin, adiponectin, insulin and IGF-1, Angiotensin II and Calcium and, cholesterol and lipoprotein. The gene discussed is LEP; the disease is metabolic syndrome.